IBDoc News

IBDoc® Update

New IBDoc® Tutorial Videos We created six new IBDoc® Portal Tutorial Videos. They help Healthcare Professionals that start using IBDoc® with the first steps of creating an account and setting up new users. Visit www.ibdoc.net for all Tutorial Videos Updated IBDoc® Flyer This flyer can be used to easily demonstrate the efficiency and practicality of IBDoc®.  [...]

IBDoc® Update Read More »

Three new studies using IBDoc®

Fecal calprotectin (fCAL) is a biomarker used for disease monitoring in patients suffering from intestinal bowel disease (IBD) since it correlates closely with mucosal healing. Calprotectin measuring requires patients to collect and return stool samples resulting in relatively low return rate of samples. Home-based fCAL testing may improve adherence. In this post three recent publications

Three new studies using IBDoc® Read More »

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

Read a recent interview with Lead Inflammatory Bowel Disease Nurse, Pearl Avery, conducted by BÜHLMANN’s UK distributor Alpha Laboratories Highlight the Article: “In the six months that we have been working with the IBDoc®, one patient was saved from hospital admission. It looked like they were having an IBD flare but the symptoms were actually

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital Read More »

IBDoc – SwissMedtech Award Nominee

At this year’s SwissMedtech Day, BÜHLMANN was nominated to receive the Swiss Medtech Award. Switzerland is listed by key rankings as the “globally most innovative country”. Medtech one of the industries heavily contributing to this ranking. Out of 25 applications BÜHLMANN Laboratories AG was chosen to present IBDoc® to a Jury of medtech and academic

IBDoc – SwissMedtech Award Nominee Read More »

IBDoc is now part of the TactioRPM

Tactio Health Group and Telia Company team up to accelerate the development of patient-centred digital health programs in Sweden and other Nordic and Baltic countries. The Swedish telecommunication company Telia, together with AbbVie Sweden, developed the IBD Home platform using the  TactioRPM platform. IBD Home is a complete IBD remote monitoring ecosystem. The IBD Home app

IBDoc is now part of the TactioRPM Read More »


Read a recent post from Amanda Appleton, the Product Manager for Calprotectin at our UK distributor Alpha Laboratories. She ends the article with following sentence: “App technology has the ability not only to improve the health of patients but to save money through rapid optimisation of treatment, enable early interventions through monitoring before conditions get